The arena of glucose treatment and obesity reduction is changing dramatically, with several promising future therapies appearing. Currently are drugs like Retatrutide, which combines dual GIP and GLP-1 receptor https://peptidences.com/home-shop/ols/products/retatrutide-1000mg-blend-with-sermoreline-1-gram1000mg--research-peptides